RxDoctor Payments Data

Amy Buckner

Family · Joplin, MONPI 1669920807

Payments from drug & device makers

$11,051in general payments, 2019–2025

Across 710 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Novo Nordisk$1K
  • GSK$808
  • Lilly USA, LLC$637
  • Abbott$615
  • plus $5K from 41 others

What the payments were for

  • Food & beverage$11,040100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,051 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$32,712
Medicare patients
162
Services billed
1,033

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$80,068
RexultiBrexpiprazole47$69,789
JardianceEmpagliflozin39$45,248
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$45,236
MounjaroTirzepatide29$34,967
VraylarCariprazine Hcl17$23,627
TrulicityDulaglutide13$23,212
MyrbetriqMirabegron33$20,438
LinzessLinaclotide22$19,240
XareltoRivaroxaban20$19,105
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$17,386
FarxigaDapagliflozin Propanediol21$16,539
EliquisApixaban15$14,515
JanumetSitagliptin Phos/Metformin Hcl19$12,525
EntrestoSacubitril/Valsartan12$8,121

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,325$80,06856 claims
Otsuka America Pharmaceutical, Inc.Rexulti$197$69,78947 claims
Lilly USA, LLCMounjaro, Trulicity$637$58,17942 claims
Boehringer IngelheimJardiance$489$45,24839 claims
GSKTrelegy Ellipta$808$45,23655 claims
AbbVieVraylar, Linzess$1,541$42,86739 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$1,361$40,58864 claims
Astellas Pharma US IncMyrbetriq, Veozah$153$26,52644 claims
MerckJanumet, Janumet Xr$341$19,26331 claims
Johnson & JohnsonXarelto$159$19,10520 claims
PfizerEliquis$536$14,51515 claims
NovartisEntresto$166$8,12112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.

Other family in Joplin

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →